Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $324,250 - $358,500
5,000 Added 12.5%
45,000 $3.05 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $2.53 Million - $2.86 Million
40,000 New
40,000 $2.78 Million
Q3 2021

Nov 15, 2021

SELL
$55.56 - $60.79 $5.56 Million - $6.08 Million
-100,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$48.42 - $60.18 $2.18 Million - $2.71 Million
-45,000 Reduced 31.03%
100,000 $5.99 Million
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $4.72 Million - $5.44 Million
100,000 Added 222.22%
145,000 $7.21 Million
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $2.18 Million - $2.61 Million
45,000 New
45,000 $2.25 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.